Published on 25th September 2014
AIM biotech Proteome Sciences has been signed up to provide to develop diagnostic products for Alzheimer's disease group Genting TauRx Diagnostic, worth $2m in upfront and milestone payments.
URL: http://www.digitallook.com/dl/news/story/22079849/...